Co-Authors
This is a "connection" page, showing publications co-authored by George Gao and Jianxun Qi.
Connection Strength
2.196
-
Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin. EMBO J. 2021 08 16; 40(16):e107786.
Score: 0.237
-
Cell entry by SARS-CoV-2. Trends Biochem Sci. 2021 10; 46(10):848-860.
Score: 0.237
-
Cross-species recognition of SARS-CoV-2 to bat ACE2. Proc Natl Acad Sci U S A. 2021 01 05; 118(1).
Score: 0.231
-
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nat Commun. 2020 09 04; 11(1):4417.
Score: 0.225
-
Molecular Basis of Binding between Middle East Respiratory Syndrome Coronavirus and CD26 from Seven Bat Species. J Virol. 2020 02 14; 94(5).
Score: 0.217
-
Light chain modulates heavy chain conformation to change protection profile of monoclonal antibodies against influenza A viruses. Cell Discov. 2019; 5:21.
Score: 0.205
-
Structural and functional insights into MCR-2 mediated colistin resistance. Sci China Life Sci. 2018 Nov; 61(11):1432-1436.
Score: 0.196
-
The Postfusion Structure of the Heartland Virus Gc Glycoprotein Supports Taxonomic Separation of the Bunyaviral Families Phenuiviridae and Hantaviridae. J Virol. 2018 01 01; 92(1).
Score: 0.187
-
Alternate binding modes of anti-CRISPR viral suppressors AcrF1/2 to Csy surveillance complex revealed by cryo-EM structures. Cell Res. 2017 Jul; 27(7):853-864.
Score: 0.180
-
Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir. Signal Transduct Target Ther. 2021 02 04; 6(1):51.
Score: 0.058
-
Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry. Emerg Microbes Infect. 2020 Dec; 9(1):1238-1241.
Score: 0.057
-
Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2. Cell Discov. 2020; 6:68.
Score: 0.057
-
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020 08; 584(7819):120-124.
Score: 0.055
-
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 2020 06 12; 368(6496):1274-1278.
Score: 0.055